(Q34789834)

English

Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts (English)

1 reference

Europe PubMed Central

4 August 2017

1 reference

based on heuristic

inferred from title

Eugènia Negredo

4

object named as

Eugènia Negredo

1 reference

Europe PubMed Central

4 August 2017

Bonaventura Clotet Sala

1

object named as

Bonaventura Clotet

1 reference

Europe PubMed Central

4 August 2017

Javier Martinez-Picado

3

object named as

Javier Martinez-Picado

1 reference

Europe PubMed Central

4 August 2017

author name string

Lidia Ruiz

2

1 reference

Europe PubMed Central

4 August 2017

Andrew Hill

5

1 reference

Europe PubMed Central

4 August 2017

Matei Popescu

6

1 reference

Europe PubMed Central

4 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2002

1 reference

Europe PubMed Central

4 August 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

4 August 2017

3

1 reference

Europe PubMed Central

4 August 2017

4

1 reference

Europe PubMed Central

4 August 2017

316-323

1 reference

Europe PubMed Central

4 August 2017

Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

1 reference

https://api.crossref.org/works/10.1310%2F67TE-GPXQ-R1LB-BPKG

21 January 2018

Identifiers

10.1310/67TE-GPXQ-R1LB-BPKG

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34789834&oldid=1988006953"